Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma

MLA

Marc A. Shuman, et al. “Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma.” Clinical Cancer Research, vol. 20, Feb. 2014, pp. 1029–41. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-13-0474.

APA

Marc A. Shuman, Lingjing Chen, Jing Li, Valerie S. Wong, Clifford A. Lowell, Pamela N. Munster, Soonmee Cha, Cigall Kadoch, & James L. Rubenstein. (2014). Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma. Clinical Cancer Research, 20, 1029–1041. https://doi.org/10.1158/1078-0432.ccr-13-0474

Chicago

Marc A. Shuman, Lingjing Chen, Jing Li, Valerie S. Wong, Clifford A. Lowell, Pamela N. Munster, Soonmee Cha, Cigall Kadoch, and James L. Rubenstein. 2014. “Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma.” Clinical Cancer Research 20 (February): 1029–41. doi:10.1158/1078-0432.ccr-13-0474.